Welcome to our dedicated page for Viavi Solutions SEC filings (Ticker: VIAV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Viavi’s dual focus on network test platforms for 5G/Open RAN and precision optical coatings means its SEC filings pack dense technical and financial data across two very different businesses. Finding where the 10-K breaks out fiber-testing backlog, or locating anti-counterfeiting royalties hidden in footnotes, can take hours.
Stock Titan distills every document in seconds. Our AI parses each Viavi quarterly earnings report 10-Q filing, flags revenue shifts between Network Enablement and Optical Security, and answers common questions like “How much did R&D for Open RAN rise this quarter?” Real-time alerts surface Viavi insider trading Form 4 transactions the moment they hit EDGAR, while concise summaries translate 8-K material events into plain English.
Here’s what you can explore today:
- Form 4 dashboards that track Viavi executive stock transactions Form 4 alongside contract news.
- AI-annotated 10-K sections—think “Viavi annual report 10-K simplified” with direct links to segment revenue, backlog, and geographic risk.
- Interactive views of 14A data for Viavi proxy statement executive compensation, helping you compare incentive plans to 5G milestones.
- Keyword alerts for “Open RAN”, “fiber monitoring”, or “currency authentication” across every filing.
Whether you’re monitoring Viavi Form 4 insider transactions in real-time, decoding an 8-K about a new aerospace contract, or simply wanting Viavi SEC filings explained simply, our platform keeps you ahead of the market. Stop scrolling through PDFs—start understanding Viavi SEC documents with AI and make informed decisions faster.
Viavi Solutions (VIAV) disclosed a director equity grant on Form 4. On 11/13/2025, the reporting person received 14,369 restricted stock units (transaction code A) at $0. The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders, and RSUs carry no expiration. After the transaction, 14,369 derivative securities were beneficially owned directly.
Viavi Solutions (VIAV) insider activity: A company director reported two open-market sales of common stock on 11/10/2025. The transactions included 23,529 shares sold at a weighted average price of $18.22 and 97,938 shares sold at a weighted average price of $18.17. Following these sales, the reporting person directly beneficially owned 27,213 shares. The filing notes that trades were executed in multiple transactions within the stated price ranges, and full trade details are available upon request.
Viavi Solutions (VIAV) reported an insider equity change by a director. On November 7, 2025, restricted stock units vested and converted into 23,529 shares of common stock at $0 per share (transaction code M). Following the settlement, the director directly holds 142,497 shares.
The RSUs convert one-for-one into common stock and vested 100% on November 7, 2025; the reported RSU balance from this grant is now 0. The filing does not show any share sales.
Viavi Solutions (VIAV) reported an insider equity event. A director settled restricted stock units, converting them into 23,529 shares of common stock on November 7, 2025 at a stated price of $0 per the award terms. Following the transaction, the director beneficially owns 75,924 shares directly. The RSU award vested 100% on November 7, 2025, and RSUs carry no expiration, per the footnotes.
Viavi Solutions Inc. (VIAV) reported a director’s RSU vesting and conversion to common stock. On 11/07/2025, 23,529 restricted stock units converted into an equal number of common shares at $0 under transaction code M. Following this event, the reporting person directly owned 203,862 shares. The RSUs vested 100% on November 7, 2025, and RSUs have no expiration date.
Viavi Solutions (VIAV) reported an insider equity change. A director acquired 23,529 shares of common stock on November 7, 2025 through the conversion of restricted stock units (Transaction Code M) at $0. Following this settlement, the director beneficially owns 65,766 shares, held directly.
The RSUs converted on a 1-for-1 basis and vested 100% on November 7, 2025. The filing shows 0 derivative securities remaining after the transaction.
VIAVI Solutions (VIAV) reported an insider equity change. On 11/07/2025, a Director settled Restricted Stock Units (RSUs) into common stock under transaction code M, receiving 6,768 shares at $0.
Following the settlement, the insider beneficially owned 6,768 shares directly, and the RSU derivative position shown in the filing moved to 0. Per the award terms, each stock unit converts into one share upon vesting; units vest on the earlier of the one-year grant anniversary or the next Annual Meeting of Stockholders.
Viavi Solutions (VIAV) filed a Form 4 disclosing an insider equity change. A director acquired 23,529 shares of common stock at $0 on November 7, 2025, coded “M,” reflecting the conversion of restricted stock units. Following the transaction, the director beneficially owns 172,053 shares in direct ownership. Each stock unit converts into one share upon vesting, and these units vested 100% on November 7, 2025; RSUs carry no expiration date.
VIAVI Solutions (VIAV) Form 4: A company director reported the vesting and settlement of restricted stock units into 6,768 shares of common stock on 11/07/2025. The transaction was coded “M,” indicating a conversion of derivatives, with the shares acquired at $0 per share. Following the transaction, the director beneficially owns 6,768 common shares directly, and holds 0 RSUs. The RSUs convert 1-for-1 into common stock and vest on the earlier of the one-year grant anniversary or the next annual meeting.
VIAVI Solutions (VIAV) disclosed a director’s RSU vesting and settlement. On November 7, 2025, 23,529 restricted stock units converted into an equal number of common shares at $0 per share (code M). No shares were sold in this filing.
Following the transaction, the reporting person directly owns 240,683 common shares. The RSUs vested 100% on November 7, 2025 and, per the disclosure, RSUs have no expiration date.